Researchers compared minithoracotomy, a minimally invasive procedure for treating degenerative mitral regurgitation, with conventional surgery, sharing their findings in JAMA. The research was previously presented as a late-breaking study at ACC.23. 

The new device was designed to remove thrombi and emboli from peripheral arteries ranging from 2 to 4 mm. 

SAVR may be even safer for low-risk patients than previously believed, according to new research published in the Journal of Thoracic and Cardiovascular Surgery. What does this tell us about patient care going forward?

Many did not lose coverage because they were deemed ineligible during the redetermination process, but due to procedural reasons, such as not completing required paperwork.

Cardiologists and other physicians have always believed cardiac transthyretin amyloidosis, a progressive heart condition associated with a high mortality rate, was irreversible. Now, though, new evidence suggests that there may be hope. 

The 88-year-old patient was originally not seen as a viable candidate for TAVR or surgery.

Multiple medical devices used during cardiopulmonary bypass and extracorporeal membrane oxygenation procedures have been voluntarily recalled due to issues with their packaging.

Motives for the hesitancy are several—transportation concerns, informational inadequacies, historical wrongs—but effective resolutions can be quite simple.